Doxorubicin-conjugated bacteriophages carrying anti-MHC class I chain-related A for targeted cancer therapy in vitro

BACKGROUND: Cancer therapy by systemic administration of anticancer drugs, besides the effectiveness shown on cancer cells, demonstrated the side effects and cytotoxicity on normal cells. The targeted drug-carrying nanoparticles may decrease the required drug concentration at the site and the distri...

Descripción completa

Detalles Bibliográficos
Autores principales: Phumyen, Achara, Jantasorn, Siriporn, Jumnainsong, Amonrat, Leelayuwat, Chanvit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259261/
https://www.ncbi.nlm.nih.gov/pubmed/25506223
http://dx.doi.org/10.2147/OTT.S69315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259261/
https://www.ncbi.nlm.nih.gov/pubmed/25506223
http://dx.doi.org/10.2147/OTT.S69315

Ejemplares similares